Aptamers Market Size Expected to Grow at a CAGR of 20.4% during the 2022-2027 Evaluation Period
The report has segmented the global aptamers market on the basis of type, application and region.
Table of contents
No headings in the article.
According to the latest report by IMARC Group, titled “Aptamers Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027”, the global aptamers market size reached US$ 1.8 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 5.4 Billion by 2027, exhibiting a growth rate (CAGR) of 20.4% during 2022-2027..
Aptamers refer to short, single-stranded DNA and RNA molecules that bind to particular targets such as proteins, carbohydrates, peptides, toxins, live cells, and small molecules. They are discovered with the help of a directed in vitro evolution technique known as systematic evolution of ligands by exponential enrichment (SELEX). It involves large libraries of degenerate oligonucleotides that are iteratively and alternately partitioned for target building. Aptamers are also used for therapeutic purposes as they are nonimmunogenic, highly sensitive, less toxic and have no variation with different preparations compared to antibodies.
Note: We are in the process of updating our reports. If you want to receive the latest research data covering the time period from 2023 to 2028, along with industry trends, market size, and competitive analysis, click on the request sample report. The team would be able to deliver the latest version of the report in a quick turnaround time.
Request a Free PDF Sample of the Report: https://www.imarcgroup.com/aptamers-market/requestsample
Market Trends:
The global aptamers market is primarily driven by its growing applications as research agents, diagnostics, biosensors, and biomarkers. In addition, the growing prevalence of life-threatening diseases, such as cancer, cardiovascular diseases (CVD) and AIDs, has also resulted in the development of new and effective detection assays based on aptamer therapy. Moreover, the increasing number of small-scale startups and extensive investments by government organizations to support clinical investigations are contributing to the market growth. Besides this, advancements in technology have enabled manufacturers to introduce next-generation products, such as Ultramers, containing aptamer templates of length up to 200 bases. These factors are anticipated to provide a positive outlook to the market in the coming years.
Aptamers Market 2022-2027 Competitive Analysis and Segmentation:
Competitive Landscape with Key Players:
The competitive landscape of the global aptamers market has been studied in the report with the detailed profiles of the key players operating in the market.
Some of these key players include:
Aptagen LLC
Aptamer Group
Aptamer Sciences Inc.
Aptus Biotech S.L.
Base Pair Biotechnologies Inc.
IBA GmbH
Kaneka Eurogentec S.A. (Kaneka Corporation)
NeoVentures Biotechnology Inc.
NOXXON Pharma
SomaLogic Inc.
TriLink BioTechnologies LLC
Vivonics Inc.
Read TOC: https://www.imarcgroup.com/aptamers-market/toc
Key Market Segmentation:
The report has segmented the global aptamers market on the basis of type, application and region.
Breakup by Type:
Nucleic Acid
Peptide
Breakup by Application:
Diagnostics
Therapeutics
Research and Developments
Others
Breakup by Region:
North America
Asia-Pacific
Europe
Latin America
Middle East and Africa
Explore Full Report Description At: https://www.imarcgroup.com/aptamers-market
Key highlights of the report:
Market Performance (2016-2021)
Market Outlook (2022-2027)
Industry Trends
Market Drivers and Success Factors
The Impact of COVID-19 on the Global Market
Value Chain Analysis
Structure of the Global Market
Comprehensive mapping of the competitive landscape
If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
Contact Us:
IMARC Group
134 N 4th St
Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Americas: +1-631-791-1145 | Europe & Africa: +44-753-713-2163 | Asia: +91-120-433-0800